General Info
Host: | Mouse |
Applications: | IHC-F/IHC-P/WB |
Reactivity: | Human/Zebrafish |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: | Mouse monoclonal antibody anti-Keratin 19 is suitable for use in Immunohistochemistry and Western Blot research applications. |
Clonality: | Monoclonal |
Clone ID: | RCK108 |
Conjugation: | Unconjugated |
Isotype: | IgG1 |
Formulation: | PBS with 0.09% sodium azide |
Dilution Range: | IHC-FIHC-p 1:10-1:50WB |
Storage Instruction: | Store at 2-8°C upon receipt. |
Information
Gene Symbol: | KRT19 |
Gene ID: | 3880 |
Uniprot ID: | K1C19_HUMAN |
Immunogen: | Cell line T24 |
Description
Tissue Specificity | Expressed in a defined zone of basal keratinocytes in the deep outer root sheath of hair follicles. Also observed in sweat gland and mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, ectocervical epithelium (at protein level). Expressed in epidermal basal cells, in nipple epidermis and a defined region of the hair follicle. Also seen in a subset of vascular wall cells in both the veins and artery of human umbilical cord, and in umbilical cord vascular smooth muscle. Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma in structures that contain dystrophin and spectrin. |
Function | Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. |
Protein Name | Keratin - Type I Cytoskeletal 19Cytokeratin-19Ck-19Keratin-19K19 |
Database Links | Reactome: R-HSA-6805567Reactome: R-HSA-6809371 |
Alternative Antibody Names | Anti-Keratin - Type I Cytoskeletal 19 antibodyAnti-Cytokeratin-19 antibodyAnti-Ck-19 antibodyAnti-Keratin-19 antibodyAnti-K19 antibodyAnti-KRT19 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance